71 related articles for article (PubMed ID: 11268561)
21. Cholinesterases: new roles in brain function and in Alzheimer's disease.
Giacobini E
Neurochem Res; 2003 Apr; 28(3-4):515-22. PubMed ID: 12675140
[TBL] [Abstract][Full Text] [Related]
22. Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
Lane RM; Potkin SG; Enz A
Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515
[TBL] [Abstract][Full Text] [Related]
23. Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?
Macdonald IR; Rockwood K; Martin E; Darvesh S
J Alzheimers Dis; 2014; 42(2):379-84. PubMed ID: 24898642
[TBL] [Abstract][Full Text] [Related]
24. A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase.
Greig NH; Utsuki T; Yu Q; Zhu X; Holloway HW; Perry T; Lee B; Ingram DK; Lahiri DK
Curr Med Res Opin; 2001; 17(3):159-65. PubMed ID: 11900310
[TBL] [Abstract][Full Text] [Related]
25. Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease?
Giacobini E
Drugs Aging; 2001; 18(12):891-8. PubMed ID: 11888344
[TBL] [Abstract][Full Text] [Related]
26. Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.
Mushtaq G; Greig NH; Khan JA; Kamal MA
CNS Neurol Disord Drug Targets; 2014; 13(8):1432-9. PubMed ID: 25345511
[TBL] [Abstract][Full Text] [Related]
27. Cholinesterases, a target of pharmacology and toxicology.
Pohanka M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):219-29. PubMed ID: 22286807
[TBL] [Abstract][Full Text] [Related]
28. Cholinesterases and the fine line between poison and remedy.
Pope CN; Brimijoin S
Biochem Pharmacol; 2018 Jul; 153():205-216. PubMed ID: 29409903
[TBL] [Abstract][Full Text] [Related]
29. A review on cholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B
Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
[TBL] [Abstract][Full Text] [Related]
30. The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease.
Rees TM; Brimijoin S
Drugs Today (Barc); 2003 Jan; 39(1):75-83. PubMed ID: 12669110
[TBL] [Abstract][Full Text] [Related]
31. Acetylcholinesterase and butyrylcholinesterase--important enzymes of human body.
Patocka J; Kuca K; Jun D
Acta Medica (Hradec Kralove); 2004; 47(4):215-28. PubMed ID: 15841900
[TBL] [Abstract][Full Text] [Related]
32. Cholinesterase inhibitors: new roles and therapeutic alternatives.
Giacobini E
Pharmacol Res; 2004 Oct; 50(4):433-40. PubMed ID: 15304240
[TBL] [Abstract][Full Text] [Related]
33. Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies.
Darreh-Shori T; Soininen H
Curr Alzheimer Res; 2010 Feb; 7(1):67-73. PubMed ID: 20205672
[TBL] [Abstract][Full Text] [Related]
34. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
Martinez A; Castro A
Expert Opin Investig Drugs; 2006 Jan; 15(1):1-12. PubMed ID: 16370929
[TBL] [Abstract][Full Text] [Related]
35. Acetylcholinesterase in Alzheimer's disease.
Talesa VN
Mech Ageing Dev; 2001 Nov; 122(16):1961-9. PubMed ID: 11589914
[TBL] [Abstract][Full Text] [Related]
36. [Cholinesterases: structure, role, and inhibition].
Bosak A; Katalinić M; Kovarik Z
Arh Hig Rada Toksikol; 2011 Jun; 62(2):175-90. PubMed ID: 21705306
[TBL] [Abstract][Full Text] [Related]
37. Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Li Q; Yang H; Chen Y; Sun H
Eur J Med Chem; 2017 May; 132():294-309. PubMed ID: 28371641
[TBL] [Abstract][Full Text] [Related]
38. A patent review of butyrylcholinesterase inhibitors and reactivators 2010-2017.
Andrisano V; Naldi M; De Simone A; Bartolini M
Expert Opin Ther Pat; 2018 Jun; 28(6):455-465. PubMed ID: 29757691
[TBL] [Abstract][Full Text] [Related]
39. Cholinergic function and Alzheimer's disease.
Giacobini E
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S1-5. PubMed ID: 12973744
[TBL] [Abstract][Full Text] [Related]
40. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease.
Small DH; Michaelson S; Sberna G
Neurochem Int; 1996; 28(5-6):453-83. PubMed ID: 8792327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
